[Analysis of prognostic factors in patients with acute coronary syndrome complicated with moderate to severe chronic kidney disease after percutaneous coronary intervention].
Jingda Cui, Fangfang Wang, Dan Li, Lijie Sun, Baoxia Chen, Jiangli Han
{"title":"[Analysis of prognostic factors in patients with acute coronary syndrome complicated with moderate to severe chronic kidney disease after percutaneous coronary intervention].","authors":"Jingda Cui, Fangfang Wang, Dan Li, Lijie Sun, Baoxia Chen, Jiangli Han","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To explore the prognostic factors of patients with acute coronary syndrome (ACS) complicated with moderate to severe chronic kidney disease (CKD) after percutaneous coronary intervention (PCI) and to establish a risk predictive model.</p><p><strong>Methods: </strong>The medical records of 148 ACS patients with moderate to severe CKD who received PCI in the Department of Cardiology, Peking University Third Hospital from September 2021 to January 2023 and completed 12-month follow-up were retrospectively analyzed. According to whether the patients had a major adverse cardiovascular disease (MACE) 12 months after PCI, they were divided into MACE group and non-MACE group. Binary Logistic regression analysis was performed on the general clinical data, clinical test results, echocardiography, coronary angiography and PCI data of the two groups of patients, the prognostic factors were analyzed by backward stepwise regression, and the risk prediction model was established. The receiver operating characteristic (ROC) curve was drawn to test the predictive efficiency of the model.</p><p><strong>Results: </strong>A total of 148 patients with ACS combined with moderate to severe CKD were included in the study, including 50 patients in the MACE group and 98 patients in the non-MACE group, and the incidence of MACE 12 months after PCI was 33.8%.Binary Logistic analysis of hospitalization data of the two groups showed that white blood cell (<i>OR</i>=1.145; 95%<i>CI</i>: 1.017-1.290; <i>P</i>=0.026), age (<i>OR</i>=1.032; 95%<i>CI</i>: 1.001-1.065; <i>P</i>=0.046) and left ventricular ejection fraction (LVEF; <i>OR</i>=0.962; 95%<i>CI:</i> 0.934-0.990; <i>P</i>=0.009) were independent influencing factors for MACE 12 months after PCI (<i>P</i> < 0.05), CKD stage was not associated with the occurrence of MACE 12 months after PCI. The risk prediction model for MACE was Logit(<i>P</i>) = 0.032× age +0.136× leukocyte-0.039×LVEF. ROC curve analysis showed that this model had good prediction efficiency, and the area under the curve (AUC) predicted by the prediction model was 0.749, 95%<i>CI</i> was 0.666 to 0.832. The sensitivity and specificity were 72% and 68%.</p><p><strong>Conclusion: </strong>The incidence of MACE was higher in ACS patients with moderate to severe CKD 12 months after PCI, and white blood cells, age and LVEF were independent factors influencing the occurrence of MACE in these patients after PCI.</p>","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"58 5","pages":"980-986"},"PeriodicalIF":0.0000,"publicationDate":"2026-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13672218/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"北京大学学报(医学版)","FirstCategoryId":"3","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To explore the prognostic factors of patients with acute coronary syndrome (ACS) complicated with moderate to severe chronic kidney disease (CKD) after percutaneous coronary intervention (PCI) and to establish a risk predictive model.
Methods: The medical records of 148 ACS patients with moderate to severe CKD who received PCI in the Department of Cardiology, Peking University Third Hospital from September 2021 to January 2023 and completed 12-month follow-up were retrospectively analyzed. According to whether the patients had a major adverse cardiovascular disease (MACE) 12 months after PCI, they were divided into MACE group and non-MACE group. Binary Logistic regression analysis was performed on the general clinical data, clinical test results, echocardiography, coronary angiography and PCI data of the two groups of patients, the prognostic factors were analyzed by backward stepwise regression, and the risk prediction model was established. The receiver operating characteristic (ROC) curve was drawn to test the predictive efficiency of the model.
Results: A total of 148 patients with ACS combined with moderate to severe CKD were included in the study, including 50 patients in the MACE group and 98 patients in the non-MACE group, and the incidence of MACE 12 months after PCI was 33.8%.Binary Logistic analysis of hospitalization data of the two groups showed that white blood cell (OR=1.145; 95%CI: 1.017-1.290; P=0.026), age (OR=1.032; 95%CI: 1.001-1.065; P=0.046) and left ventricular ejection fraction (LVEF; OR=0.962; 95%CI: 0.934-0.990; P=0.009) were independent influencing factors for MACE 12 months after PCI (P < 0.05), CKD stage was not associated with the occurrence of MACE 12 months after PCI. The risk prediction model for MACE was Logit(P) = 0.032× age +0.136× leukocyte-0.039×LVEF. ROC curve analysis showed that this model had good prediction efficiency, and the area under the curve (AUC) predicted by the prediction model was 0.749, 95%CI was 0.666 to 0.832. The sensitivity and specificity were 72% and 68%.
Conclusion: The incidence of MACE was higher in ACS patients with moderate to severe CKD 12 months after PCI, and white blood cells, age and LVEF were independent factors influencing the occurrence of MACE in these patients after PCI.
期刊介绍:
Beijing Da Xue Xue Bao Yi Xue Ban / Journal of Peking University (Health Sciences), established in 1959, is a national academic journal sponsored by Peking University, and its former name is Journal of Beijing Medical University. The coverage of the Journal includes basic medical sciences, clinical medicine, oral medicine, surgery, public health and epidemiology, pharmacology and pharmacy. Over the last few years, the Journal has published articles and reports covering major topics in the different special issues (e.g. research on disease genome, theory of drug withdrawal, mechanism and prevention of cardiovascular and cerebrovascular diseases, stomatology, orthopaedic, public health, urology and reproductive medicine). All the topics involve latest advances in medical sciences, hot topics in specific specialties, and prevention and treatment of major diseases.
The Journal has been indexed and abstracted by PubMed Central (PMC), MEDLINE/PubMed, EBSCO, Embase, Scopus, Chemical Abstracts (CA), Western Pacific Region Index Medicus (WPR), JSTChina, and almost all the Chinese sciences and technical index systems, including Chinese Science and Technology Paper Citation Database (CSTPCD), Chinese Science Citation Database (CSCD), China BioMedical Bibliographic Database (CBM), CMCI, Chinese Biological Abstracts, China National Academic Magazine Data-Base (CNKI), Wanfang Data (ChinaInfo), etc.